Nasdaq:US$16.36 (-0.09) | HKEX:HK$26.10 (-0.45) | AIM:£2.71 (+0.01)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate